AzTrials
AzTrials

DepressionNCT04265859

Changes in Brain Function Through Repeated Emotion Regulation Training

A study testing Cognitive Behavioral Training and Mindfulness in people with Depression, run by Michael Stevens at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a pilot study that will investigate how two psychotherapies (re-interpretation and mindfulness) alter brain function. This information will be used to gain understanding of how repeated emotion regulation practices influence the brain and to develop a focused, tactic-based emotional regulation remediation… Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Depression
What is being tested?
Cognitive Behavioral Training and Mindfulness
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
1 Mar 2021to Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Ages 18-50
  • Right-handed
  • High-school level of education (11th grade attainment for 18 year-olds is acceptable if they haven't completed their final year yet)
  • >8th grade English reading level to complete self-report evaluations (most are only available in English).
  • For the depressed group, elevated scores on the Beck Depression Inventory - II to validate depressive symptoms.

Who cannot join

  • Head injury sufficient to have caused >30 minutes lost consciousness
  • Past or current CNS disease (e.g., MS, epilepsy, tumor, etc.)
  • Brain lesion identified by MR (structural MR scans will be reviewed by a radiologist for the presence of clinical neuropathology that may affect cognitive task performance)
  • Hypertension or juvenile-onset diabetes (current treatment with antihypertensives or insulin)
  • Current pregnancy (menstruating females will be tested)
  • DSM-IV Axis I lifetime history of Bipolar disorder, PTSD, OCD, psychotic disorder, Tourette's disorder, or any Pervasive Developmental Disorder (e.g., Autistic disorder, PDD NOS, etc.)
Show all 9Show fewer
  • For the depressed group, current PTSD
  • Current DSM-IV substance dependence, ADHD, Conduct Disorder, MDD
  • Any current psychotropic medications

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • Institute of Living/Hartford Hospital

    Hartford, Connecticut, 06106

    Karen L Kesten, MS, 860-545-7776, Karen.kesten@hhchealth.org

    Julie Reid, MS, (860) 545-7788, Julie.reid@hhchealth.org

    Recruiting

Other trials in United States

About this study

This is a pilot study that will investigate how two psychotherapies (re-interpretation and mindfulness) alter brain function. This information will be used to gain understanding of how repeated emotion regulation practices influence the brain and to develop a focused, tactic-based emotional regulation remediation approach for treatment of ADHD.

Read the detailed description

The goal of this pilot study is to collect preliminary data that will allow the investigators to formulate theories about ER-related brain function change during intervention-like training that will be tested in larger, externally-funded grant proposals submitted to the National Institutes of Health. The investigators are not especially interested in any existing specific, manualized therapeutic technique. Existing ER-based psychotherapies typically incorporate a variety of related interventions, not all of which focus on the ER component itself. Instead, the investigators will focus on the "building blocks" of such therapies, i.e., the ER interventions themselves and their effect on negative emotional reactions. Here, the investigators ask a specific question - How does ER-elicited brain function change with repeated sessions of guided practice of various ER techniques? In other words, does increasing familiarity or mastery of ER skills through practice change brain function, and how? There are logical hypotheses about the likely nature of brain function changes that can be gleaned from prior neuroimaging research. For instance, if prefrontal cortex activation is important to ER, perhaps practice simply increases such activation. However, pilot work for the current NIMH R01 suggests instead that ER practice might work by enhancing the functional integration among key frontolimbic regions. Complicating such hypotheses is the recognition that different ER tactics engage many distinct brain regions depending on which approach is employed. So a participant's individual brain function differences prior to ER training might be a potent determinant for what sorts of neural changes result from repeated practice. Because all these issues must be evaluated through the lens of a preliminary study before any coherent theoretical model can be formulated, a pilot study is proposed here. Not only will this provide empirical data upon which to base future research, conducting such a pilot will showcase any methodological hurdles or challenges that need to be overcome in order to successfully conduct a larger-scale study.

Conditions
Depression
Being tested
Cognitive Behavioral Training, Mindfulness
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavioral TrainingBehavioural

    Also called CBT

    The CBT-based regulation training involves using a cognitive strategy that instructs participants to reappraise situations in positive or less negative ways.

  • MindfulnessBehavioural

    The MBT-based regulation training involves using a mindfulness strategy that instructs participants to notice and accept their feelings without judgment or intent to act upon them.

Study groups in NCT04265859
Study groupRoleWhat they receive
DepressedExperimentalParticipants in this group will be randomized to receive either the CBT training (n=10) or Mindfulness training (n=10).
Receives: Behavioral: Cognitive Behavioral Training; Behavioral: Mindfulness
Healthy ControlOtherParticipants in this group will be randomized to receive either the CBT training (n=10) or Mindfulness training (n=10).
Receives: Behavioral: Cognitive Behavioral Training; Behavioral: Mindfulness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. fMRI Brain Scan

    fMRI-assessed brain function data, examined either to detect any changes in activation amplitude ("level of activity") in a priori ER-linked brain regions-of-interest (ROIs) or changes in the degree of functional connectivity among them.

    Measured: Visit one and repeated again at Visit two (approximately 4 weeks later)

Secondary outcomes (1)
  1. Beck Depression Inventory - II and State Trait Anxiety Inventory

    Depression and anxiety scales (pre and post scores, as evidenced by a decrease in total scores from each scale)

    Measured: Enrollment and repeated again at Visit two (approximately 4 weeks later)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2020
  2. Study start1 Mar 2021
  3. Primary completionOct 2023 (estimated)
  4. Study completionOct 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Adults having mild-to-moderate levels of depression or who will serve as non-depressed/anxious controls. Participants in each of these study groups then will be randomized into two conditions, each of which will receive 2 assessment/MRI appointments along with 6 sessions of guided practice/training in either 1) Re-interpretation or 2) Mindfulness ER techniques. Immediately after the first and sixth practice sessions, participants also will undergo fMRI so that brain function relative to that stage of practice can be assessed.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04265859
Sponsor's protocol ID
R-HCC-2016-0177
Status last verified
Aug 2022
First submitted
10 Feb 2020
Last updated
2 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Behavioral Training and Mindfulness in people with Depression, run by Michael Stevens at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Karen L Kesten, MS ((860) 545-7776, Karen.kesten@hhchealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

fMRI Brain Scan (time frame: Visit one and repeated again at Visit two (approximately 4 weeks later)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in